Smilegate Investment is a top-tier venture capital and private equity firm based in Seoul, South Korea, originally founded as MVP Venture Capital in 1999. The firm invests across all stages from seed to growth and buyout, with a focus on content, gaming, ICT, healthcare, and climate. It is part of the Smilegate Group and manages approximately KRW 1.4 trillion in assets.
Deal activity increased 600% year-over-year (7 deals in the last 12 months). Average disclosed round size is $20.2M (across 61 rounds with reported amounts).
Portfolio
64
Fund Size
—
Top Stage
Series A
Last 12 Mo
7
Team
Ahn, Byung-Hwi
Senior Vice President
Ally Lee
Senior Vice President
Chang, Heung-Sun
Senior Vice President
Hwang, Chul-Min
Senior Vice President
Kim, Kyoung-Hwan
Senior Vice President
Kim, You-Suk
Senior Vice President
Kim, Young-Min
Senior Vice President
Lee, Jong-Ho
Senior Vice President
Park, Jung-In
Senior Vice President
Seo, Kyung-Woo
Senior Vice President
Son, Ji-Won
Senior Vice President
Yoon, Hee-Wook
Vice President
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
| Company | Round | Amount | Date |
|---|---|---|---|
 Fitogether | Unknown | $7.2M | Aug 2026 |
 WIRobotics | Series B | — | May 2026 |
 RLWRLD Inc. | Seed | $26M | Feb 2026 |
 AFINIT | Series E | $22M | Feb 2026 |
 AiderX | Series A | — | Jan 2026 |
 WeRobotics | Series B | — | Jan 2026 |
 Rootrix | Series A | — | Jan 2026 |
 Pinetree Therapeutics, Inc. | Series B | $47M | Oct 2025 |
 ImmunoForge | Series C | — | Sep 2025 |
 Habit factory | Series D | — | Jan 2025 |
 Appcharge | Series B | $58M | Jan 2025 |
| Appcharge | Series B | $26M | Nov 2024 |
| MMarvin AI | Unknown | $6.6M | Jun 2024 |
| WIRobotics | Series B | $68M | May 2024 |
 MedInTech | Series A | — | May 2024 |
 StealthMole Intelligence | Series A | $7M | Mar 2024 |
| SStealthmole | Series A | $7M | Mar 2024 |
 MyRealTrip | Series F | — | Jan 2024 |
| SStealthmole | Unknown | $7M | Jan 2024 |
 Moreh | Series B | $22M | Oct 2023 |
| FFreeWillin | Series B | — | Jul 2023 |
| BBuyMed | Series B | $51.5M | May 2023 |
 Payhere | Series B | $11.3M | Jan 2023 |
 Modhaus | Series A | $8M | Jan 2023 |
 BoostImmune | Series A | — | Jun 2022 |
Top Co-Investors
Last updated: 20 October 2026